NVRS.CN Noveris Health Sciences Inc.
Company Analysis
Latest News
🔴 Noveris Health Sciences is trading 5.3% down today as hotter August producer inflation raises rate concerns
Noveris Health Sciences is trading at CA$0.09, down -5.26%, as broader risk-off pressure intensified on September 10, 2026. • U.S. indices are down more than...
🔴 Noveris Health Sciences is trading 14.29% down today amid broader risk aversion
Noveris Health Sciences is trading 14.29% down at CA$0.09 amid broader risk aversion, after falling from the September 8 close of CA$0.10. - No new...
🔴 Noveris Health Sciences is trading 9.52% down today with no confirmed catalyst identified
Noveris Health Sciences is trading at $0.10, down -9.52%, with no new company-specific announcement or confirmed catalyst identified for September 9, 2026. -...
🔴 Noveris Health Sciences is trading 21.74% down today with no clear company-specific catalyst identified
Noveris Health Sciences is trading 21.74% down at $0.09, with no clear company-specific catalyst identified for September 8, 2026. - Recent disclosures...
🟢 Noveris Health Sciences is trading 8.7% up today with no clear catalyst identified
Noveris Health Sciences is trading at $0.12, +8.70% now, with no clear September 8, 2026 catalyst identified. • Recent company disclosures include Q2 net...
🟢 Noveris Health Sciences is trading 13.04% up today amid biotech momentum after Purple Biotech’s patent allowance
Noveris Health Sciences is trading at $0.13, up 13.04%, on broader biotech-sector momentum. - Available coverage links the sentiment to Purple Biotech’s U.S....
🟢 Noveris Health Sciences is trading 13.04% up today on biotech momentum, with no clear catalyst
Noveris Health Sciences is trading higher on September 3, 2026, at CA$0.13, up 13.04%, as sector momentum supports the move despite no clear company-specific...
🟢 Noveris Health Sciences is trading 8.7% up today as biotech strength supports risk appetite
Noveris Health Sciences is trading at CA$0.12, up +8.70%, mainly as biotech-sector strength supports risk appetite; no clear company-specific catalyst has been...
🔴 Noveris Health Sciences is trading 8.33% down today — no clear catalyst identified
Noveris Health Sciences is trading 8.33% down at $0.11, with no clear company-specific catalyst identified for September 2, 2026. - Available market coverage...
🔴 Noveris Health Sciences is trading 14.81% down today as biotech ETF XBI falls 4.24%
Noveris Health Sciences is trading 14.81% down at $0.12 amid broad biotech weakness and a risk-off market session. - Major indexes are also lower as investors...
🔴 Noveris Health Sciences is trading 7.41% down today as biotech weakness weighs on speculative healthcare shares
Noveris Health Sciences is trading at $0.12 (-7.41%) as biotechnology weakness and a broader risk-off session weigh on speculative healthcare shares. - No new...
🔴 Noveris Health Sciences is trading 13.33% down today amid broad biotech weakness
Noveris Health Sciences is trading 13.33% down at $0.13 amid broad weakness in biotechnology. - The XBI ETF was down 4.24% during the regular session. - No...
🔴 Noveris Health Sciences is trading 6.67% down today with no direct company catalyst found
Noveris Health Sciences is trading at CA$0.14 (-6.67%) with broader market risk-off sentiment potentially contributing. - No new company announcement was...
🟢 Noveris Health Sciences is trading 6.67% up today — no new company announcement found
Noveris Health Sciences is trading at CA$0.16, up +6.67% on August 31, 2026, with no new company announcement found during the morning session. - The latest...
Noveris Health Sciences Faces a CA$500,000 Dilution Test — Can a Micro-Cap Biotech Afford to Keep Tapping Shareholders?
Shares of Noveris Health Sciences (NVRS.CN) slid 11.4% to CA$0.15 on August 28 as the company moved to close a proposed CA$500,000 convertible-debenture...
🔴 Noveris Health Sciences is trading 11.43% down today amid proposed convertible-debenture dilution overhang
Noveris Health Sciences is trading 11.43% down at CA$0.15, amid investor pressure linked to a proposed private placement of up to CA$500,000 in convertible...
🔴 Noveris Health Sciences is trading 5.71% down today amid proposed convertible-debenture dilution overhang
Noveris Health Sciences is trading 5.71% down at CA$0.17 as biotech-sector weakness pressured higher-risk growth stocks during August 28, 2026 trading. - No...
🟢 Noveris Health Sciences is trading 5.88% up today amid broader risk appetite; no confirmed company catalyst
Noveris Health Sciences is trading at CA$0.18, up +5.88%, most likely reflecting broader risk appetite, with the Nasdaq Composite up 0.70%, rather than a...
🟢 Noveris Health Sciences is trading 12.12% up today amid biotechnology-sector strength
Noveris Health Sciences is trading at CA$0.18, up +12.12%, mainly supported by biotechnology-sector strength. - No new company-specific announcement was...
🟢 Noveris Health Sciences is trading 9.09% up today amid stronger biotech sentiment
Noveris Health Sciences is trading 9.09% up at CA$0.18, with the move appearing mainly supported by stronger biotechnology sentiment. - No new...